Skip to main content

Table 4 Parameter estimates for clinical AE count incidence using conventional Poisson model

From: Joint modelling of multivariate longitudinal clinical laboratory safety outcomes, concomitant medication and clinical adverse events: application to artemisinin-based treatment during pregnancy clinical trial

Characteristic

Coefficient

SE

95% CI

P-value

Treatment

 ASAQ

0.1838

0.0645

0.0574, 0.3102

0.004

 DHAPQ

–0.0255

0.0679

−0.1587, 0.1076

0.707

Maternal age

0.0208

0.0071

0.0068, 0.0347

0.004

Primigravid

0.1208

0.0731

−0.0224, 0.2641

0.098

Second trimester

0.3768

0.0829

0.1943, 0.5192

< 0.001

Constant

−0.3901

0.2021

−0.7862, 0.0060

0.054